GlaxoSmithKline Slammed With $90 Million Verdict for Patent Infringement

Drug Industry Daily
A A
Pharma giant GlaxoSmithKline infringed upon UK-based Vectura’s patent on particle manufacturing and must pay the company $89.7 million, a federal jury in Delaware ruled.

To View This Article:

Login

Subscribe To Drug Industry Daily